JUDIE STEINBACHER: Open Payments
NPI 1427097047 · SELINSGROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,665 in 92 payments from 23 companies in 2025. Trend: 2023 $1,250 · 2024 $1,293 · 2025 $1,665
Food & beverage: $1,665
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $279 |
| Lilly USA, LLC | 15 | $275 |
| Novo Nordisk Inc | 15 | $247 |
| AstraZeneca Pharmaceuticals LP | 10 | $195 |
| Exact Sciences Corporation | 3 | $81 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| Xeris Pharmaceuticals, Inc. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
Products named: MOUNJARO, VRAYLAR, QULIPTA, Ozempic, The Cologuard Plus Collection Kit, Wegovy, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
